Numinus and MAPS Pursuing Trial for MDMA-Assisted Psychotherapy for PTSD

Numinus Wellness and the Multidisciplinary Association for Psychedelic Studies Public Benefit Corp. (MAPS PBC), a MAPS subsidiary, have announced they are seeking approval for the use of MDMA-assisted psychotherapy for post-traumatic stress disorder through a compassionate access trial in Canada.

Click here to read more.